C4XD, Manchester drug firm, to delist from AIM
Manchester-based drug discovery company C4X Discovery Holdings plc (C4XD) has announced the proposed cancellation of its ordinary shares on AIM and re-registration as a private limited…
Manchester-based drug discovery company C4X Discovery Holdings plc (C4XD) has announced the proposed cancellation of its ordinary shares on AIM and re-registration as a private limited…
Shares of Manchester-based drug discovery company C4X Discovery Holdings plc rose as much as 40% after it announced that AstraZeneca has triggered an $11 million…
Shares of Manchester-based drug discovery company C4X Discovery Holdings plc fell as much as 10% after it published results for the year ended July 31, 2023,…
Manchester-based drug discovery company C4X Discovery Holdings plc announced that Indivior will acquire the proprietary rights to C4XD’s oral Orexin-1 receptor antagonist C4X_3256 (INDV-2000) for substance…
Manchester-based drug discovery company C4X Discovery Holdings plc announced that Eva-Lotta Allan will step down as chair after five years of service with immediate effect….
Manchester-based drug discovery company C4X Discovery Holdings plc announced the appointment of Nick Ray as its chief scientific officer (CSO) with immediate effect. Ray joined C4XD in…
Manchester-based drug discovery company C4X Discovery Holdings plc on Thursday said its annual loss widened, but it remains positive in its outlook, citing a partner programme…
Shares of Manchester-based drug discovery company C4X Discovery Holdings plc rose as much as 37% on Monday after it announced it signed an exclusive worldwide licensing…
Manchester-based drug discovery company C4X Discovery Holdings announced on Thursday morning a placing of shares with institutional investors to raise up to £5.7 million. C4X said the…
Manchester-based drug discovery company C4X Discovery Holdings plc announced it has received a milestone payment of €3 million from Sanofi under the IL-17A Inhibitor programme…
Manchester-based drug discovery company C4X Discovery Holdings plc announced the appointment of Dr Cathy Tralau-Stewart, PhD, as chief scientific officer as of January 4, 2022….
Manchester-based drug discovery company C4X Discovery Holdings plc said on Monday that “over the next 12-24 months” it will look to “advance and augment” its…
Manchester-based drug discovery company C4X Discovery Holdings plc on Thursday published results for the six months ended January 31, 2021, with its CEO telling investors…
Shares of Manchester-based drug discovery company C4X Discovery Holdings plc rose about 12% on Monday after it announced its subsidiary, C4X Discovery Limited, has signed an exclusive…
Shares of Manchester-based drug discovery company C4X Discovery Holdings plc (C4XD) fell about 58% on Thursday as it announced it raised £7 million from a share placing…
Shares of Manchester-based drug discovery company C4X Discovery Holdings plc (C4XD) soared 99% after it said it signed a licensing agreement worth up to $294 million with…
Manchester-based drug discovery company C4X Discovery Holdings said it raised £7 million in a share placing to support the firm’s expansion plans. AIM-listed C4X said 8,235,294…